2019
DOI: 10.1002/lary.27882
|View full text |Cite
|
Sign up to set email alerts
|

Oncologic outcomes after surgery for locally aggressive basal cell carcinoma of the head and neck

Abstract: Objective: Although basal cell carcinoma (BCC) is the most common skin cancer, locally aggressive BCC of the head and neck is rare and not well studied.Study Design: Retrospective review of patients who underwent primary surgical resection of locally aggressive head and neck BCC at a single tertiary academic center.Results: Eighty-seven patients with 98 tumors demonstrated a 5-year Kaplan-Meier estimated recurrence-free survival of 64.5%, overall survival of 83.3%, and disease-specific survival of 98.3%. Intra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 20 publications
(28 reference statements)
0
3
0
Order By: Relevance
“…The majority of BCCs occur in the head and neck [3]. Carcinomas of the external auditory canal (EAC) are rare tumors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The majority of BCCs occur in the head and neck [3]. Carcinomas of the external auditory canal (EAC) are rare tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Surgery on BCC of the EAC is quite challenging. Due to the particular location of these tumors, the ability to perform a wide excision remains difficult, in addition to the aggressiveness of certain histological subtypes [3].…”
Section: Discussionmentioning
confidence: 99%
“…Radiotherapy can be considered when surgery is not feasible for locally advanced tumors. Targeted chemotherapy, such as Sonic Hedgehog pathway inhibitors, is used for metastatic or locally advanced basal cell carcinoma that cannot be treated with surgery or radiation [ 6 , 7 ]. Locally aggressive basal cell carcinoma of head and neck patients experience a high rate of local recurrence but low disease-specific mortality when treated with primary surgery and selected use of adjuvant treatment [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%